C002
טבע תעשיות פרמצבטיות בע"מ
2
Public
TEVA- PHARMACEUTICAL INDUSTRIES LTD.
2529
Corporation no:
520013954
Stock Exchange/Market:
טבע
310
380
P.O.B
3190
,
Petach Tikva
49131
,
,
Tel:
03-9267297
,
03-9267281
Fax:
03-9267429
E.mail address:
DORIT@TEVA.CO.IL
Date of transmission:
22/01/2004
Time of broadcast:
17:11
17:00:25
Reference:
2004-02-061314
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA ANNOUNCES PRICING OF $1 BILLION CONVERTIBLE DEBENTURE OFFERING
Convertibles- Pricing-final-220104_isa.pdf
Please find attached a press release announced today in the U.S. and its unofficial hebrew translation. The binding release is the english version.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure:
28/12/2003
Name of the Signatory
:
Suesskind Dan
Position of Signatory in the reporting corporation:
Chief Financial Officer
Basel
Telephone:
02-5892840
,
Facsimile:
02-5892839
,
E-mail:
dan.suesskind@teva.co.il